U.S. Electric Utilities Stock News

Tarsus Pharmaceuticals recently presented at the 46th Annual William Blair Growth Stock Conference in Chicago and the Jefferies Global Healthcare Conference in New York, highlighting its eye-care portfolio and commercial progress. These conferences gave the company a high-visibility forum to emphasize growing real-world adoption of XDEMVY, supported by intensive direct-to-consumer marketing efforts. We’ll now examine how accelerating XDEMVY awareness and uptake, spotlighted at these...

In recent days, Clear Street analyst Tim Moore highlighted Willdan Group’s potential upside, citing expected revenue and adjusted EBITDA growth from power grid modernization and rising demand for energy-efficient and AI datacenter solutions, while company insiders sold about US$6.1 million of stock over the past three months. This combination of bullish analyst commentary on AI datacenter exposure and concurrent insider selling offers a contrasting signal about management’s and the market’s...

On 3 June 2026, Bristol Myers Squibb announced a clinical trial collaboration and supply agreement under which Arcus Biosciences will provide its investigational HIF-2a inhibitor casdatifan for new combination arms in the Phase 1/2 ROSETTA RCC-208 study in advanced renal cell carcinoma, while both parties retain rights to their respective assets in this non-exclusive deal. This collaboration highlights growing external interest in casdatifan as a potential component of combination regimens,...

Popular (BPOP) is back in focus after recent analyst commentary highlighted upward revisions to earnings estimates and a strong momentum style score. This has drawn attention to how these signals may influence sentiment around its stock. See our latest analysis for Popular. Recent price action has been supportive for that improving sentiment, with a 90 day share price return of 19.32% and a 1 year total shareholder return of 51.92%. Multi year total shareholder returns above 100% point to...

Yelp’s antitrust push against Google puts search power in the spotlight Yelp (YELP) is pressing its antitrust case against Google, arguing that Google’s dominance in search should require broader access to its search index and user interaction data for rival services. The company is asking the court to rely on earlier findings about Google’s market power instead of revisiting them. Google, in contrast, argues that AI tools and more localized search trends mean the current market needs a fresh...

Nabors Industries recently faced increased investor attention after geopolitical tensions and sector-wide energy volatility raised concerns about operational risks, particularly in the Gulf region. At the same time, some analysts view Nabors as trading at a substantial discount to their fair value estimates, despite ongoing margin and capital intensity headwinds. We’ll now examine how rising geopolitical risk in key operating regions could influence Nabors Industries’ existing investment...

Over the last 7 days, the United States market has experienced a 4.1% drop, yet it remains up by 21% over the past year with anticipated earnings growth of 18% per annum in the coming years. In this fluctuating environment, identifying stocks that may be priced below their estimated value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.

Over the last 7 days, the United States market has experienced a 4.1% drop, yet it remains up by 21% over the past year with earnings forecasted to grow by 18% annually. In this context of fluctuating market conditions, companies with high insider ownership and strong revenue growth potential can offer intriguing opportunities for investors seeking stability and alignment of interests between management and shareholders.

Over the last 7 days, the United States market has dropped 4.1%, but it remains up by 21% over the past year, with earnings expected to grow by 18% annually in the coming years. Investing in penny stocks—often smaller or newer companies—can still offer growth opportunities, especially when these stocks are backed by strong financial health. We'll explore several penny stocks that stand out for their financial strength and potential for long-term success.

Over the last 7 days, the United States market has dropped by 4.1%, though it has risen by an impressive 21% over the past year, with earnings forecasted to grow annually by 18%. In this dynamic environment, identifying dividend stocks that offer reliable income and potential for growth can be a prudent strategy for investors seeking stability amidst market fluctuations.

EMCOR Group (EME) is back in focus after a run of earnings and revenue results that topped consensus estimates, paired with higher earnings forecasts and upbeat sector commentary around AI-linked infrastructure demand. See our latest analysis for EMCOR Group. The share price has pulled back sharply in the short term, with a 1-day share price return of 6.2% and a 30-day share price return of 16.6%. This comes despite a 1-year total shareholder return of 64.9%, which may indicate recent profit...

Earlier this week, Federated Hermes introduced the Federated Hermes Money Market Management Digital Treasury Fund–Reserve Shares, a US dollar cash and short-term US Treasury vehicle designed to meet the GENIUS Act’s reserve and liquidity standards for payment-stablecoin issuers. This launch marks Federated Hermes’ entry into regulated stablecoin infrastructure, linking its traditional money market expertise with fast-growing digital payment platforms. Next, we’ll explore how this GENIUS...

EHang Holdings Limited reported weaker Q1 2026 results on June 9, with CNY 25.66 million in sales and a CNY 125.96 million net loss, while reaffirming its 2026 revenue guidance of RMB 600 million. Alongside these results, the company authorized a new US$30 million share repurchase program funded from existing cash, signaling management’s confidence as it advances pilotless eVTOL commercialization. We’ll now examine how reaffirmed 2026 revenue guidance, despite soft Q1 sales, affects EHang’s...

Prologis (PLD) is back in focus after exceeding Q1 2026 earnings per share estimates and raising full year earnings guidance, as strong global logistics real estate demand contributes to higher investor attention. See our latest analysis for Prologis. At a share price of US$145.77, Prologis has eased slightly in the latest session but still carries a 90 day share price return of 10.52% and a 1 year total shareholder return of 39.02%. This indicates that momentum has been building around its...

Recently, commentary highlighted that Global Partners’ extensive fuel distribution network could benefit from higher energy prices linked to renewed geopolitical tensions and inflation pressures. This focus on its exposure to rising commodity prices adds a new angle to how the market views Global Partners’ earnings sensitivity to macro shocks. Now we’ll examine how this increased attention on Global Partners’ leverage to higher energy prices may reshape its broader investment...

With inflation pressures, energy shocks and rate expectations keeping markets on edge, many investors are looking for companies that already show high return on equity, sound past performance and robust balance sheets. Instead of chasing short term stories tied to every data release or central bank headline, this approach focuses on businesses that appear financially resilient and efficient. Using our Solid Balance Sheet and Fundamentals screener, this article highlights 3 stocks that...

Leadership transition and why it matters for CorVel stock CorVel (CRVL) has set July 1, 2026 as the date for a major leadership transition, with long-time executive Sarah Scott taking over as CEO and President and Michael G. Combs moving to Executive Chair. See our latest analysis for CorVel. The leadership news comes after a mixed run for investors, with a 90 day share price return of 18.76% and a 1 year total shareholder return that declined 43.41%. This suggests weaker long term momentum...

In early June 2026, Air Products and Chemicals marked the completion of a US$70 million expansion of its Missouri Manufacturing and Logistics Center in Maryland Heights, adding more than 70 hires to support rising demand in biogas, hydrogen recovery, aerospace nitrogen, and cleaner marine fuels. This expansion is Air Products Membrane Solutions' largest single-site investment to date, underlining how energy transition applications are becoming a central focus of the company’s industrial gas...

Wholesale inflation just surprised to the upside, with May PPI and energy costs running hotter than expected, and the market now leaning toward higher for longer interest rates. That mix can pressure many stocks, but it can also highlight companies where dividend income and relatively resilient demand look more appealing. This article focuses on large, established dividend payers that are directly exposed to this inflation story. It will walk through 3 stocks from our Inflation-Resilient...

Global growth warnings, inflation pressures, and conflict driven supply risks are pushing commodity and natural resource stocks back into the spotlight. With the World Bank projecting 2.5% global growth for 2024 and highlighting the risk of sharper slowdowns, investors are again weighing how exposure to energy, materials, and agriculture related businesses might respond to higher price volatility and prolonged tight financial conditions. This article highlights three large, financially stable...

Thea Energy, Inc. previously announced collaborations with NVIDIA, Synopsys, Argonne National Laboratory, and Princeton Plasma Physics Laboratory to build an AI-powered digital twin for its Helios fusion power plant, while Synopsys also expanded its AI-driven EDA and IP collaboration with Samsung Foundry on advanced 2nm and 3DIC nodes. These partnerships highlight how Synopsys is extending its multiphysics simulation and AI-accelerated design tools from semiconductor manufacturing into...

In recent days, Hancock Whitney received a Momentum Style Score of B and a Zacks Rank of #2 (Buy), alongside upward revisions to its earnings estimates, signaling analysts’ increasingly favorable expectations for its financial performance. This shift in analyst sentiment, reflected in both the ranking and earnings estimate upgrades, points to growing confidence in how Hancock Whitney may convert its current initiatives into stronger profitability. Next, we will examine how these upward...

In early June 2026, OPKO Health amended its agreement with Nicoya Therapeutics, securing a 15% equity stake while preserving eligibility for up to US$115 million in potential RAYALDEE-related payments in Greater China and surrounding territories. This deeper Nicoya partnership adds an ownership position on top of royalties and milestones, tying OPKO Health more directly to RAYALDEE’s regional commercialization outcomes. Next, we’ll examine how OPKO’s new 15% Nicoya stake and reshaped...

Recently, H.C. Wainwright reiterated its positive view on MoonLake Immunotherapeutics after encouraging Sonelokimab data were presented at the EULAR conference and the company completed its final FDA pre-BLA meeting for hidradenitis suppurativa. The news also highlighted that investors are closely watching upcoming Sonelokimab clinical milestones and data readouts across multiple inflammatory indications, underscoring the drug’s central role in MoonLake’s pipeline. Next, we will examine how...